Back to Results
First PageMeta Content
Nephrology / Organ failure / Syndromes / Eculizumab / Immunosuppressants / Pharmaceutical Benefits Scheme / Hemolytic-uremic syndrome / Alexion Pharmaceuticals / Chronic kidney disease / Medicine / Health / Anatomy


Document Date: 2014-10-01 21:56:23

Open Document

File Size: 73,47 KB

Share Result on Facebook

Company

Alexion Pharmaceuticals Australasia Pty Ltd / /

Country

Australia / /

Currency

USD / /

IndustryTerm

proposed treatment algorithm / treatment of acute manifestations of the disease / clinical management / submission algorithm / treatment of patients with aHUS disease / treatment of atypical Haemoytic Uraemic Syndrome / clinical management algorithm / treatment of atypical Haemolytic Uraemic Syndrome / literature search / treatment algorithm / /

MedicalCondition

HIV / headache / leukopenia / diarrhoeanegative haemolytic uraemic syndrome / aHUS disease / thrombotic thrombocytopaenic purpura / clinically definable disease / chronic conditions / purpura / end-stage renal failure / disease / meningococcal infection / atypical Haemoytic Uraemic Syndrome / atypical Haemolytic Uraemic Syndrome / Shigatoxin producing E.coli infection HUS / infection / renal failure / thrombocytopenic purpura / acute renal failure / Syndrome / /

MedicalTreatment

renal transplants / antibiotics / vaccination / antibiotic prophylaxis / plasma exchange / kidney transplant / vaccinations / renal dialysis / dialysis / renal transplant / /

Organization

Pharmaceutical Benefits Advisory Committee / American Society of Complement Mutations / Australian Government / Sporadic and Familial aHUS Society of Nephrology / /

Position

Trial ID/ First Protocol title/ Publication title Publication citation author / /

Product

Soliris / ADAMTS-13 / /

Technology

alpha / diagnostic tests / antibodies / management algorithm / proposed treatment algorithm / treatment algorithm / submission algorithm / clinical management algorithm / dialysis / /

SocialTag